Friday, April, 19, 2019 04:17:40

Category: Health

Crescita, Tetra NHP partner to enhance dermatology product portfolio

The collaboration will effectively help optimize the delivery of Beta-C and several other active ingredients into patient’s skin and local tissues. Canada’s dermatology firm, Crescita Therapeutics Inc. and leading cannabinoid-derived drug provider, Tetra Bio-Pharma’s subsidiary, Tetra Natural Health (NHP) have recently announced an arrangement to …

HOOKIPA attains HIV collaboration and license agreement with Gilead

The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …

GeoVax & Enesi team up to develop vaccines administered by ImplaVax®

The biotechnology company GeoVax Labs, Inc. has reportedly announced to have joined hands with the pharmaceutical firm Enesi Pharma to develop needle-free solid-dose vaccine formulations by using its unique Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform along with Enesi’s ImplaVax® device and formulation technology. …

Myriad Genetics announces the publication of Vectra(R) clinical study

The outcome of the Vectra(R) clinical studies were published in the journal Rheumatology. The adjusted Vectra(R) test is significantly more effective than conventional methods in predicting radiographic progression in individuals suffering from Rheumatoid Arthritis. Myriad Genetics, Inc. (Myriad), a leading American molecular diagnostic firm, has …